1
Defibrotide in Children With High Risk Kawasaki Disease
Condition(s):Kawasaki DiseaseLast Updated:November 3, 2021Recruiting
DEFITELIO: 24 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
Defibrotide TMA Prophylaxis Pilot Trial
Condition(s):Thrombotic MicroangiopathiesLast Updated:September 16, 2021Completed
3
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
Condition(s):Sickle Cell Disease; Acute Chest SyndromeLast Updated:November 22, 2021Recruiting
4
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
Condition(s):COVID; Sars-CoV2; COVID-19; Acute Respiratory Distress SyndromeLast Updated:November 12, 2021Completed
5
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Condition(s):Sickle Cell DiseaseLast Updated:March 31, 2022Recruiting
6
5-day Defibrotide Treatment for Hepatic SOS/VOD
Condition(s):Sinusoidal Obstruction Syndrome; Veno-occlusive Disease; Bone Marrow Transplant ComplicationsLast Updated:April 23, 2021Recruiting
7
Defibrotide for the Treatment of Severe COVID-19
Condition(s):Covid19Last Updated:July 29, 2021Recruiting
8
Defibrotide in COVID-19 Pneumonia
Condition(s):Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failureLast Updated:February 7, 2022Active, not recruiting
9
Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
Condition(s):Veno-occlusive DiseaseLast Updated:January 20, 2017Completed
10
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Condition(s):Hepatic Veno-Occlusive DiseaseLast Updated:November 30, 2017Completed